Newsroom | MarketersMEDIA Newswire

November 26, 2025

Creative Biostructure Upgrades Liposome Service to Enable Tailored Drug Delivery Solutions

Amid the swift progress in global drug delivery innovations, Creative Biostructure, a top-tier service provider in structural biology and nanomedicine, revealed today an extensive upgrade to its liposome service . This enhancement is set to deliver more nuanced and tailored liposome production services for corporate clients, addressing needs from early-stage research to clinical application phases. Tailored Liposome Solutions Utilizing its versatile liposome platform, Creative Biostructure has crafted specialized options designed for a variety of uses: Cancer Treatment Applications • Heat-Responsive Liposomes: Offer targeted drug delivery to affected areas, activating medicine release through localized heat therapy. • Asymmetric Liposomes: Improve targeting of tumors and lessen overall toxicity by emulating the natural properties of cell membranes. Transdermal Treatment Systems • Transfersomes: Present fresh approaches for skin-delivered therapies by boosting the flexibility and penetration capabilities of lipid layers. • Ethosomes: Designed for enhanced dermal and transdermal delivery, they significantly improve how effectively drugs penetrate the skin. Advanced Delivery Options • Light-Activated Liposomes: Facilitate accurate medication distribution via activation by external light. • Pharmacosomes: Boost the absorption and effectiveness of drugs, especially those with low solubility, aligning with personalized treatment protocols. Comprehensive Quality Assurance Framework Creative Biostructure has implemented a comprehensive quality system that ensures our products meet high standards at every stage, from source materials through to finished products. Key Testing Parameters • Particle Size and Charge Analysis (Zeta Potential) • Encapsulation efficiency and in vitro release profile • Stability and structural properties of products Diverse Industry Applications Cosmetic-grade liposomes: Act as effective carriers for active ingredients in premium skincare lines. Food-grade liposomes: Enhance the stability and bioavailability of nutrients. Benefits and Commitment to Quality of Service With a full technology upgrade, Creative Biostructure has established a robust service model for liposome production across the entire drug development continuum. Joanna, Chief Marketing Officer at Creative Biostructure, commented, "We want to be more than just a technology provider; we want to deliver fully integrated solutions. By applying advanced liposome technology, we are helping our partners solve drug delivery challenges, including targeted cancer therapies and transdermal delivery systems. Our structured quality protocols will help ensure rigorous standards through each step, from initial formulation studies to production, providing a basis for clients to establish their innovations as commercially viable." With a complete technical solution, Creative Biostructure welcomes collaboration with pharmaceutical and biotech companies worldwide. For more on their liposome services and tailored solution development, please see their dedicated webpage: Liposome Production Services . The experts at Creative Biostructure are ready to support a variety of drug delivery projects from concept to feasibility and ultimately through to production scale.

November 26, 2025

Health

Healthcare Cloud Computing Market Set to Reach USD 93.41 Billion by 2030, Driven by Cloud Adoption and AI Integration

Introduction The Healthcare Cloud Computing market size reached USD 54.69 billion in 2025 and is forecast to grow to USD 93.41 billion by 2030, reflecting an 11.3% CAGR. This growth reflects an 11.3% CAGR over the forecast period. Increasing demand for cloud-based solutions is transforming healthcare IT infrastructure, enabling providers and payers to enhance patient care, streamline operations, and reduce costs. Cloud platforms are now central to managing clinical and non-clinical workloads, telehealth services, and real-time analytics across hospitals, clinics, and diagnostic networks. North America remains the largest market, while Asia-Pacific is emerging as the fastest-growing region. Key Trends The healthcare cloud computing market trends highlight several factors contributing to its rapid adoption: Widespread IT Adoption Across Healthcare Settings Hospitals and clinics are increasingly replacing legacy systems with scalable cloud platforms that support real-time data processing, IoMT device feeds, and predictive analytics. Smaller healthcare facilities leverage SaaS-based electronic health records (EHRs) to access advanced decision-support tools without heavy infrastructure investments. Integrated delivery networks benefit from unified patient records, enhancing cross-facility consultations and overall clinical efficiency. Cost-Saving and Scalability Advantages Cloud computing reduces capital expenditure on hardware and minimizes the need for large IT teams to maintain infrastructure. Elastic cloud environments absorb traffic spikes during high-demand periods, such as vaccination campaigns or peak claims processing, without overprovisioning resources. Payers benefit from faster claims adjudication, while providers reduce energy and real estate costs associated with traditional data centers. Access to Advanced Analytics and Machine Learning Tools Cloud platforms provide healthcare organizations with easy access to AI and ML tools for imaging segmentation, population health analytics, and predictive modeling. Radiology departments can accelerate diagnosis through cloud-based AI triage, while providers leverage natural language processing to extract actionable insights from unstructured clinical notes. Cloud-based analytics support personalized patient care and improve value-based care performance. Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights: https://www.mordorintelligence.com/ja/industry-reports/global-healthcare-cloud-computing-market-industry?utm_source=marketersmedia Market Segmentation The healthcare cloud computing market analysis includes segmentation by application, deployment, service, end user, and geography: By Application Clinical Information Systems (CIS) Non-clinical Information Systems (NCIS) By Deployment Private Cloud Public Cloud Hybrid Cloud By Service Software-as-a-Service (SaaS) Infrastructure-as-a-Service (IaaS) Platform-as-a-Service (PaaS) By End User Healthcare Providers Healthcare Payers By Geography North America South America Europe Middle east&Africa Asia pacific Key Players Several organizations are driving healthcare cloud computing market growth through innovative solutions and strategic partnerships. Key players include Microsoft Corporation, IBM Corporation, Oracle Corporation, Amazon Web Services (AWS), and Google Cloud. These companies provide comprehensive cloud solutions, ranging from SaaS EHR platforms to cloud-based AI analytics, enabling healthcare providers and payers to optimize operations, improve patient care, and maintain compliance with evolving regulations. IBM Corporation Oracle Dell Technologies Koninklijke Philips N.V. Amazon Web Services (AWS) Conclusion The healthcare cloud computing market growth is supported by increasing cloud adoption, the need for scalable and cost-effective IT solutions, and the integration of advanced analytics and AI tools. As providers and payers continue to migrate from on-premise systems to cloud platforms, the market is expected to maintain steady expansion through 2030. Key trends such as FHIR-based interoperability, AI-assisted clinical workflows, and multicloud environments will further drive demand. Healthcare organizations are set to benefit from improved patient care, operational efficiency, and reduced IT costs, reinforcing the critical role of cloud computing in modern healthcare infrastructure. Related Reports: North America Healthcare Cloud Computing Market : The North America Healthcare Cloud Computing Market is analyzed across several dimensions. By application, it is segmented into Clinical Information Systems (CIS) and Non-Clinical Information Systems (NCIS). In terms of deployment, the market is categorized into private and public cloud solutions. By service type, it covers Software-as-a-Service (SaaS), Infrastructure-as-a-Service (IaaS), and Platform-as-a-Service (PaaS). The market is also segmented by end users, including healthcare providers and healthcare payers, and geographically across the United States, Canada, and Mexico. About Mordor Intelligence: Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals. With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics. For any inquiries or to access the full report, please contact: [email protected] https://www.mordorintelligence.com/

November 25, 2025

Health

Harvest SS Health Emphasizes Preventive Care, Education, and Counseling as Core Focus

Harvest SS Health, a trusted name in the healthcare sector, continues to strengthen its commitment to patient well-being by prioritizing preventive care, education, and counseling as integral parts of its practice. The organization is focused on promoting a patient-centric approach where each individual’s health needs are addressed with precision and professionalism. The representative at the firm stated, “We are delighted to serve the community by prioritizing health, wellness, and patient education as part of our continued commitment to quality care.” With a dedicated team of experienced medical professionals and support staff, Harvest SS Health integrates advanced treatments with personalized care. The firm highlights its role as one of the primary care providers in Florida , offering comprehensive solutions designed to address a broad spectrum of healthcare needs. The practice places significant importance on guiding patients toward informed decisions through effective education and counseling, ensuring that preventive care remains at the forefront of its approach. Harvest SS Health further underlines its emphasis on inclusivity by employing a team of experienced multilingual professionals. These qualified experts work closely with patients, providing personalized solutions that align with their individual health concerns and goals. As a health care provider in Florida, the organization remains committed to promoting preventive care and patient education, supporting individuals in making informed decisions about their overall well-being The representative at the firm further remarked, “Harvest SS Health’s commitment to maintaining high standards of patient care has played a pivotal role in strengthening its reputation within the community.” Through a consistent focus on quality care and patient education, Harvest SS Health has successfully reinforced its credibility and trustworthiness among its patients. Disclaimer: This content is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider for personalized recommendations.

November 25, 2025

Health

CD BioGlyco's Glycoprotein Enrichment Platform: Enabling Reliable Detection from Challenging Biological Samples

Glycoproteins are pivotal in disease development, how the immune system reacts to pathogens and cellular communication. For this reason, they are particularly important targets for biomarker discovery and new therapies. However, scientists have historically faced substantial challenges in their analysis due to their scarcity, heterogeneous structural nature, and the complexity of their biological environment. In response to this challenge, CD BioGlyco has developed a better platform for glycoprotein and glycopeptide purification from complex samples. This new technology is a step towards more specificity, clarity, and consistency for glycoprotein analysis . In developing this technology, a robust multi-lectin affinity glycoprotein enrichment protocol was created to yield optimal preparation for mass spectrometry. Real-World Evidence Research Issue: Enrichment of Complex Samples Rather than relying on sourcing solutions solely from research, the CD BioGlyco platform provides an all-inclusive solution specifically developed for true biological samples. Here are a few highlights from the many benefits to be had: • This platform will work across a variety of sample types, including serum, various tissues, and cell contents, or even exosomes and extracellular vesicles. • It enables enrichment of O - and N -glycoproteins, with custom multi-lectin mix options. • It requires a very small sample size with proven confidence when detecting glycoproteins in trace amounts, significantly expanding the opportunities for biomarker risk determination. The platform provides researchers with the ability to go beyond the typical barriers to detection to reach trustworthy and relevant insight into glycosylation sites. Testing for these enriched or isolated samples involves careful consideration of technical aspects such as sample provenance and data confidence. CD BioGlyco likewise consider three major prescriptive scientific technical specifications: CD BioGlyco outlines three primary elements that reinforce the platform: Precision in Analysis: The system is compatible with state-of-the-art, high-resolution MS setups, ensuring glycosylation sites are pinpointed with assurance. Streamlined Enrichment Process: Developed from years of refinement, this process enhances the accuracy and efficiency in complex sample setups. Comprehensive Scientific Assistance: A collaborative team of glycobiologists and analytical experts are on hand to guide study planning, technique selection, and data analysis. The robustness of the platform is grounded in the well-established principle of lectin-based enrichment. This approach, which leverages the specific binding of lectins to carbohydrate motifs, is recognized for its effectiveness in isolating glycoproteins from complex mixtures. This principle is particularly pivotal for studies involving small sample volumes, as it enhances the detection of low-abundance glycoproteins, making it highly relevant and applicable to this platform. Applications Spanning Basic to Translational Research The upgraded enrichment approach is versatile, suitable for: · Uncovering biomarkers in cancer and related inflammatory conditions · Analyzing glycosylation patterns in therapeutic antibodies · Investigating mechanisms and integrating multi-omics data · Quantifying changes in glycosylation patterns Such versatile applications establish the platform as an essential resource for research institutions, clinical studies, and pharmaceutical innovations. About CD BioGlyco With a worldwide footprint, CD BioGlyco offers pioneering services in glycobiology analysis, ranging from glycoprotein enrichment and glycosylation-site mapping to site-specific quantification and analyzing glycosylation occupancy. For further details, feel free to explore our Glycoprotein Enrichment service page.

November 25, 2025

Health

Creative BioMart Enlarged Its Protein Portfolio for Cell and Gene Therapy Research

Creative BioMart, a leader in serving science with quality proteins and unique protein manufacturing techniques, is pleased to announce the expansion to its protein offerings to support scientists in the field of genome editing, RNA-targeted interventions, and advanced cell engineering. Cell and gene therapy (CGT) products represent a medical revolution by harnessing cells or genetic material to treat or prevent disease, with significant therapeutic efficacy and mode of action benefits over standard drugs. From targeted genetic corrections with Cas9 to the untapped potential of RNA-focused Cas13, these essential tools are at the forefront of precision medicine. These proteins have numerous applications in research and drug development. CRISPR-associated proteins including Cas9, Cas12, and Cas13 allow for precise genome or RNA changes that aid in gene correction, knockout, and transcriptional regulation. Additional proteins involved in DNA repair, recombination, and gene control promote effective editing while also maintaining cellular stability. These proteins work together to construct modified cell lines, evaluate viral vectors, and conduct functional investigations, allowing researchers to discover new treatment techniques and advance translational applications. Upon this update, Creative BioMart now provides nearly more than 1,000 related proteins covering cas proteins, cytokines, growth factors and so on, from over 10 different species (human, chicken, cynomolgus, e.coli, monkey, rabbit, rat, etc.). Each proteins is produced using optimized expression systems, like bacterial, mammalian, and insect cells, and undergoes thorough characterization for purity, identity, and functional activity. Some of the featured products includ e: Recombinant Streptococcus pyogenes cas9 protein Recombinant Cas9 Nuclease Protein Recombinant Leptotrichia wadei Cas13a, His-tagged Active Recombinant Streptococcus pyogenes M1 cas9 Protein, His-tagged Recombinant Streptococcus pyogenes Cas9 Protein, His-tagged Recombinant Lachnospiraceae Cas12 Protein, GST-tagged Recombinant S. pyogenes Cas9 Protein, His-tagged ... “With extensive experience in molecular and cell biology, we can provide expert guidance throughout protein selection, experimental design, and downstream applications.” said Linna, the chief marketing staff at Creative BioMart. “Based on your specific needs, we can provide a wide range of unique, reliable, and flexible customized services.” Beyond those core proteins, Creative BioMart also provides PROTAC targets, labeled Cart-T proteins, protein kinase, CD antigen , biomarker, organoid culture cytokines, and more for diversified research needs. According to Linna, this Thanksgiving, the company offers 15% off all products and services at Creative BioMart for a limited time, to show appreciation for its customers’ being an essential part of its journey all along the year 2025. To view the whole list of cell and gene therapy protein products provided by Creative BioMart, please visit https://www.creativebiomart.net/product/cell-and-gene-therapy_4137.htm .

November 25, 2025

Health

Matexcel Introduces Advanced Compositional Analysis Services to Enhance Materials Research

Matexcel, a leading provider in material science, today announced the launch of its enhanced compositional analysis services, offering researchers and manufacturers a comprehensive toolkit for understanding material composition, purity, and elemental distribution. Compositional analysis is always used to describe the quantitative chemical/elemental analysis of a specific material. It is a useful tool in materials science research because it enables researchers to identify unknown materials and understand the structure-property relationships for each component as well as their synergistic behaviors in order to characterize significant changes in material structure and elemental distribution. To help unlock the secrets of chemical composition, Matexcel now provides state-of-the-art compositional analysis services supported by a suite of analytical techniques tailored to different sample types, including: Mass spectrometry (MS) GC-MS, LC-MS, and ICP-MS, to detect and quantify elements and compounds with high precision. High-performance liquid chromatography (HPLC) To separate complex mixtures and analyze individual components. X-ray fluorescence (XRF) and atomic absorption spectroscopy (AAS) To perform non-destructive elemental identification and quantification. Vibrational spectroscopy FTIR, Raman, and near-infrared (NIR), to reveal chemical bonds and molecular structures. UV-visible spectrometry For fast, sensitive detection of target molecules. Nuclear magnetic resonance (NMR) To provide structural information and evaluate sample purity. Depending on the project, these methods can be combined and tailored to produce both quantitative and qualitative data, as well as high-resolution spatial mapping as required. One of the Matexcel representative speakers, Johnson, highlighted the benefits of the service: "We can provide you with in-depth information on structure-property relationships, allowing you to understand how the composition of your material contributes to its features and behavior. Regardless of the type of your sample, we have a variety of complementary techniques suited to analyze them.” According to Johnson, the service can be applied in diversified fields, including: l Unveiling structure-composition-property relationships and enhancing research's credibility. l Monitoring the quality and integrity of materials and maintaining high-quality standards. l Detecting hazardous elements in materials and promoting healthier and safer surroundings. l Increasing production efficiency by understanding how different material compositions affect the process. In addition to compositional analysis, Matexcel provides comparative analysis, contamination analysis, corrosion analysis, cryo-electron microscopy analysis, formula analysis , flammability testing, microplastic analysis, etc., for customers to choose. Of note, in the season of giving thanks, Matexcel now provides 10% off to all products and services, to express its appreciation for customers’ continued trust and partnership, from Nov. 10 to Nov. 30, 2025. To know more details about the enhanced compositional analysis service provided by Matexcel, please visit https://www.matexcel.com/compositional-analysis.html .

November 25, 2025

Health

Addiction Resource Center Announces Evening Telehealth Substance Abuse Services

A newly announced telehealth service from Addiction Resource Center addresses significant, documented barriers that those in the workforce face when pursuing treatment for substance abuse disorders. Addiction Resource Center's evening intensive outpatient program (IOP) allows participants to receive clinical services remotely without sacrificing employment, education, or family caregiving responsibilities. Interested parties can learn more at https://eveningiop.com The new program responds to a persistent treatment access crisis: only 23.6% of individuals needing substance use treatment received it in 2023, according to the Substance Abuse and Mental Health Services Administration. Seven published studies comparing telehealth with in-person addiction treatment found no difference in retention rates, patient satisfaction, therapeutic alliance, or substance use outcomes, establishing that remote care delivers results equivalent to traditional clinic-based models. The Evening IOP from Addiction Resource Center represents a clinically-proven middle ground between residential and standard outpatient care, which typically requires nine to twenty hours per week of structured programming. Participants engage in group therapy, individual counseling, and specialized services while maintaining their work, school, and family commitments. According to ARC's team of clinicians, this model allows individuals to make progress toward long-term recovery without compromising responsibilities. "Our telehealth program allows working professionals and students the flexibility to attend sessions during lunch breaks or evenings, preserving their daily routines while maintaining continuity of care," says a spokesperson. "It eliminates the barriers of attendance at a physical clinic and time off work for appointments, which often discourage individuals from seeking treatment." The program also addresses privacy concerns and stigma through confidential online sessions conducted on HIPAA-compliant platforms. Addiction Resource Center's EveningIOP also removes barriers that disproportionately affect rural residents and individuals with mobility challenges. Transportation challenges and limited provider availability in rural settings often prevent consistent participation in traditional programs, but telehealth allows access from any location with an internet connection. The platform delivers a range of therapeutic services, including mental health counseling, group therapy, family therapy, and treatment for co-occurring conditions such as depression and anxiety. Qualified counselors conduct one-on-one sessions to address underlying causes of substance use, develop coping skills, and establish recovery goals. Personalized treatment plans are tailored to individual needs, with bilingual counselors available to serve English- and Spanish-speaking populations. To learn more, please visit https://eveningiop.com/

November 25, 2025

Health

Private GP clinic Sloane Street Surgery marks one year of same-day diagnostic testing, transforming infection care for London patients

Sloane Street Surgery is marking one year since introducing same-day BioFire diagnostic testing, a rapid molecular testing system that has transformed how the clinic diagnoses and treats infections. The practice remains one of the few GP surgeries in London offering this level of same-day PCR-based testing for respiratory, gastrointestinal and pneumonia-related infections. BioFire testing works by identifying bacteria, viruses and parasites within hours rather than days. Panels are available for respiratory, GI and pneumonia investigations, offering rapid diagnoses that enable earlier treatment, preventing the risk of complications and reducing unnecessary antibiotic use. The clinic is keen to increase the use of the technology because it supports safer prescribing and helps combat antibiotic resistance. It also supports public health efforts, allowing earlier identification of infectious pathogens and helping to limit their spread. Patients of all ages are benefiting from the service: After weeks of coughing and fever, BioFire identified patient James’s Mycoplasma pneumoniae, allowing the clinic to prescribe the correct antibiotics the same day. Following travel, Emma returned with severe diarrhoea but BioFire was able to quickly detect Giardia, enabling immediate targeted treatment and helping her avoid hospital admission. Four-year-old Poppy had a high fever, but BioFire confirmed RSV, delivering immediate reassurance and preventing unnecessary antibiotics. Patients experiencing a persistent cough, fever, diarrhoea or other respiratory/GI symptoms can choose to access this private same-day testing service by booking an appointment for rapid clinical assessment. Results are fast, accurate and provide significant peace of mind. For more information about Sloane Street Surgery, use the contact details below:

November 25, 2025

Health

Chicago Gold Coast Stellate Ganglion Block For PTSD & Anxiety Treatment, Update

The clinic, which serves Gold Coast and nearby neighborhoods including the Near North Side, River North, Streeterville, Lincoln Park, and the West Loop, is now offering SGB as part of its broader range of physician-led treatments aimed at helping patients manage complex mental health conditions. More details can be found at https://chicagoivsolution.com/sgdptsd/ The Stellate Ganglion Block is an outpatient procedure that uses a small injection of local anesthetic to target the stellate ganglion, a nerve cluster involved in the body’s fight-or-flight response. By calming this system, the treatment may help reduce symptoms connected to hyperarousal, which can include heightened stress, sleep disruption, intrusive memories, and persistent anxiety. The clinic notes that SGB is particularly suitable for individuals who have tried traditional therapies without experiencing adequate improvement. “SGB offers patients another path when standard approaches haven’t provided enough relief,” said a clinic representative. “Many people living with PTSD or severe stress symptoms are searching for additional options, and this procedure gives them an opportunity to explore a different type of support.” The procedure is performed by Dr. Eugene Lipov, a specialist known for his extensive work with SGB in trauma-related conditions. Each treatment is done under ultrasound guidance for precision, typically takes 10 to 30 minutes, and involves minimal downtime. Depending on the patient’s response, both sides of the neck may be treated within a short period, and sedation can be provided for comfort. Growing interest in SGB has followed research evaluating its potential role in supporting trauma-related symptoms. A multi-center randomized study published in JAMA Psychiatry reported stronger outcomes for SGB compared to placebo, contributing to wider clinical acceptance. While responses differ from person to person, the clinic explains that the procedure may offer helpful symptom reduction for patients seeking additional treatment avenues. For individuals with more complex needs, IV Solutions & Ketamine Centers of Chicago can coordinate plans that combine SGB with intravenous ketamine therapy, another treatment used to support patients with treatment-resistant depression, PTSD, and chronic anxiety. All services are provided in a private, medically supervised setting staffed by anesthesiologists, registered nurses, and trained clinical personnel. Interested parties can find additional information at https://chicagoivsolution.com/

November 24, 2025

Health

Precision Health: A Global Call to Action

Precision health is advancing at extraordinary speed, reshaping how we predict illness, diagnose disease, and tailor treatment. With gene sequencing costs falling from £2 billion to £230 in just two decades and AI now analysing complex multi-omic data, the potential for personalised, effective care has never been greater. But as the Global Impact Committee’s latest report makes clear, this progress risks deepening inequity unless global systems act now. The GIC – an independent advisory board supporting Beamtree’s mission to mobilise the power of data for a healthier, happier world – examines both the opportunity and the challenge. As the report states, “The impact of precision health will be as great as medical landmarks such as the discovery of antibiotics and advances in imaging technology.” Yet services remain concentrated in major cities, therapies can cost more than £1.5 million per patient, and entire regions such as Africa, home to 19% of the global population but less than 2% of genetic datasets, are at risk of being left behind. Beamtree CEO Marek Stepniak emphasises why this work matters: “Precision health represents one of the most profound shifts in modern healthcare. But its true value will only be realised if every community, not just the privileged few, can access the benefits. This report outlines the actions and collaborations needed to ensure precision health becomes equitable, sustainable, and safe at scale.” The report calls for coordinated action across governments, regulators, and healthcare systems – reforms that can make precision health accessible, trustworthy, and truly global. Its message is clear: innovation alone won’t deliver better outcomes; equitable access will. Read the full report here to explore the insights and recommendations shaping the future of precision health.

November 24, 2025

Health

Sprout Consulting Group Expands Healthcare Marketing and Communications Solutions Nationwide

As healthcare continues to undergo rapid technological change, the need for robust marketing strategies that connect patients with the care they need is more important than ever. Sprout Consulting Group, led by Chief Strategist Ursula Douglas, works with healthcare leaders to develop and implement strategies that not only improve visibility but also align with organizational goals and enhance the overall patient experience. Each engagement brings together strategists, creatives, and digital technologists to deliver solutions that combine vision with the precision required in today’s healthcare environment. Aligning Digital and Traditional Strategies for Greater Impact With a background in both corporate and entrepreneurial healthcare settings, Douglas brings nearly 15 years of experience to her role. She has held multiple roles within one of the largest medical technology companies in the world and has partnered with leading medical and research institutions, including Morehouse School of Medicine in collaboration with the National Institutes of Health, giving her unique insight into the challenges and opportunities within the healthcare sector. Sprout’s digital transformation model integrates both traditional and digital marketing approaches, ensuring that healthcare organizations can engage with patients more effectively across all touchpoints. “Digital transformation is not just about technology,” Douglas said. “It is about aligning mission and communication to make care more connected, accessible, and human. When marketing, communications, and strategy work in harmony, it becomes a catalyst for meaningful transformation within the organization.” As healthcare systems adapt to a more digital environment, the demand for transparent, effective communication has never been greater. Studies show that while 70% of patients now prefer digital communication for healthcare services, fewer than half feel their needs are being adequately met. This disconnect presents a significant opportunity for healthcare organizations to evolve their marketing strategies and bridge the gap between patient expectations and their actual experiences. Sprout Consulting Group partners with healthcare organizations to address this challenge by integrating clarity, insight, and personalization into both internal and external communication strategies. Why Patient Experience Is Critical to Healthcare Marketing Sprout Consulting Group’s approach emphasizes the critical role patient experience plays in driving successful marketing outcomes. Research from Deloitte indicates that health systems with excellent patient experience scores see up to 50% higher net margins compared to those with lower scores. Furthermore, studies consistently show that positive patient experiences lead to better adherence to care plans, improved health outcomes, and higher levels of patient satisfaction. This connection between experience and outcomes underscores why healthcare marketing must evolve beyond awareness to become a driver of engagement, clarity, and alignment. Sprout’s strategy helps healthcare organizations focus not just on attracting patients but also on unifying their internal and external efforts so that education and outreach become catalysts for lasting impact. The firm’s work extends upstream to help leadership teams align internal stakeholders, ensuring that marketing and communication strategies directly support broader business objectives and patient-centered outcomes. By integrating marketing with organizational strategy, Sprout ensures that every touchpoint contributes to the goal of improved patient care. “Our clients partner with us because we understand the intersection of marketing, strategy, and healthcare delivery,” said Douglas. “By aligning internal strategy with external engagement, we help organizations create stronger, more meaningful connections with patients.” A Comprehensive Approach to Healthcare Marketing Sprout Consulting Group, a Houston, TX based healthcare marketing agency , sets itself apart by blending deep industry expertise with strategic insight to help healthcare organizations communicate with clarity and impact.Purpose-built for collaboration, Sprout integrates expertise in healthcare strategy, communications, and digital technology to deliver solutions that balance creativity, compliance, and impact. Their holistic approach integrates branding, digital strategy, and patient experience alignment, ensuring that all marketing strategies are not only impactful but also sustainable. In recent years, the company has collaborated with a range of healthcare and public health organizations, helping them navigate the complexities of digital marketing while staying true to their mission and values. Sprout’s clients include a wide range of stakeholders, including healthcare providers, pharmaceutical companies, and public health institutions. “We take a comprehensive approach to every engagement,” said Douglas. “Our goal is to help healthcare organizations communicate effectively with patients, whether through storytelling, digital campaigns, or internal messaging. The result is an integrated marketing strategy that amplifies the organization’s mission and improves overall outcomes.” Redefining Healthcare Marketing’s Future As the digital landscape continues to evolve, Sprout Consulting Group is at the forefront of transforming healthcare marketing. By focusing on alignment, engagement, and measurable outcomes, the firm is helping healthcare organizations rethink how they engage with patients and communities. “Marketing should never be seen as a separate or secondary function,” said Douglas. “It is not just about producing more content or utilizing more channels. True transformation happens when marketing is fully integrated with the organization’s mission to strengthen stakeholder alignment and patient engagement.” Sprout’s model bridges creative strategy with operational depth, empowering healthcare organizations to connect innovation with empathy and create impact that endures as the healthcare landscape continues to evolve. About Sprout Consulting Group Sprout Consulting Group is a healthcare marketing and communications firm dedicated to helping healthcare organizations transform their marketing strategies to enhance patient experience and drive digital transformation. Led by Chief Strategist Ursula Douglas, Sprout combines strategic expertise with digital capability to deliver integrated solutions across the healthcare ecosystem. The firm specializes in aligning brand strategy, digital transformation, and patient experience for healthcare, MedTech, pharmaceutical, and public health organizations. Learn more at www.sproutconsultinggroup.net Media Contact Ursula Douglas Chief Strategist Sprout Consulting Group [email protected] www.sproutconsultinggroup.net

Health News

Calm Blue Waters Counseling Expands Therapy Services in Huntersville, NC

South Florida Trim Clinic: Revolutionizing Weight Loss with Physician-Led, Telehealth Services

NeuroPraxis Institute Announces Groundbreaking NPI–WAFAB Clinical Interview to Revolutionize ADHD Diagnosis for AFAB Adults

2025 Wheel Rotary Lawn Edger Market Research Report-PW Consulting

Creative Biostructure Upgrades Liposome Service to Enable Tailored Drug Delivery Solutions

Healthcare Cloud Computing Market Set to Reach USD 93.41 Billion by 2030, Driven by Cloud Adoption and AI Integration

Harvest SS Health Emphasizes Preventive Care, Education, and Counseling as Core Focus

CD BioGlyco's Glycoprotein Enrichment Platform: Enabling Reliable Detection from Challenging Biological Samples

Creative BioMart Enlarged Its Protein Portfolio for Cell and Gene Therapy Research

Matexcel Introduces Advanced Compositional Analysis Services to Enhance Materials Research

Addiction Resource Center Announces Evening Telehealth Substance Abuse Services

Private GP clinic Sloane Street Surgery marks one year of same-day diagnostic testing, transforming infection care for London patients

Chicago Gold Coast Stellate Ganglion Block For PTSD & Anxiety Treatment, Update

Precision Health: A Global Call to Action

Sprout Consulting Group Expands Healthcare Marketing and Communications Solutions Nationwide

ALL NEWS